Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

04.05.22	Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise (PR Newswire)
29.04.22	Abbott to Release Metabolic Nutrition Formulas (PR Newswire)
29.04.22	Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months (PR Newswire)
28.04.22	Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company's Amulet™ Device (PR Newswire)
28.04.22	New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes (PR Newswire)
27.04.22	Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes (PR Newswire)
26.04.22	Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation (PR Newswire)
25.04.22	Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health App (PR Newswire)
21.04.22	Abbott Q1 EPS, Sales Rise, ANTM Hits All-time High, Healthcare Services' Q1 Results Trump Estimates (RTTNews)
20.04.22	Abbott: FY22 Adj. EPS Guidance Remains Unchanged (RTTNews)
20.04.22	Abbott Laboratories Q1 Profit Increases, beats estimates (RTTNews)
20.04.22	Abbott Reports First-Quarter 2022 Results (PR Newswire)
12.04.22	Retailers Ration Baby Formula Sales Amid Widespread Shortage (RTTNews)
04.04.22	Abbott: FDA Approves Aveir Pacemaker For Treatment Of Patients With Slow Heart Rhythms (RTTNews)
04.04.22	Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms (PR Newswire)
30.03.22	Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain (PR Newswire)
28.03.22	Abbott Hosts Conference Call for First-Quarter Earnings (PR Newswire)
24.03.22	Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin (PR Newswire)
01.03.22	Abbott Recalls Another Lot Of Simila After A Second Infant-fatality (RTTNews)
21.02.22	FDA Approves Expanded Indication For Abbott's CardioMEMS HF System (RTTNews)
21.02.22	Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure (PR Newswire)
18.02.22	Abbott Declares 393rd Consecutive Quarterly Dividend (PR Newswire)
17.02.22	Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant (PR Newswire)
07.02.22	Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial (PR Newswire)
26.01.22	Abbott Q4 Profit Tops Estimates; Net Sales Up 7.7% On Organic Basis (RTTNews)
26.01.22	Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast (PR Newswire)
12.01.22	Abbott Receives FDA Clearance For Cardiac Mapping System (RTTNews)
12.01.22	Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms (PR Newswire)
11.01.22	ACELYRIN Appoints Melanie Gloria as Chief Operating Officer (PR Newswire)
06.01.22	Abbott Announces Future of Biowearables at Consumer Electronics Show (PR Newswire)
04.01.22	Abbott Hosts Conference Call for Fourth-Quarter Earnings (PR Newswire)
04.01.22	Abbott's Proclaim™ XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S. (PR Newswire)
21.12.21	Abbott to Present at J.P. Morgan Healthcare Conference (PR Newswire)
10.12.21	Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman (PR Newswire)
10.12.21	Abbott Increases Quarterly Dividend for 50th Consecutive Year (PR Newswire)
16.11.21	Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development (PR Newswire)
15.11.21	Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI) (PR Newswire)
12.11.21	Abbott's New Leadless Pacemaker System Meets Main Goal In Pivotal Trial (RTTNews)
12.11.21	Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial (PR Newswire)
09.11.21	Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology (PR Newswire)
03.11.21	Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations (PR Newswire)
20.10.21	Abbott Laboratories Boosts FY21 Outlook - Quick Facts (RTTNews)
20.10.21	Abbott Laboratories Q3 adjusted earnings Beat Estimates (RTTNews)
20.10.21	Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance (PR Newswire)
18.10.21	Jason Sudeikis Joins Abbott, Real Madrid at New York Stock Exchange to Support Children's Health (PR Newswire)
18.10.21	Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally (PR Newswire)
30.09.21	Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center for Malnutrition Solutions (PR Newswire)
23.09.21	Abbott Hosts Conference Call for Third-Quarter Earnings (PR Newswire)
20.09.21	Abbott Reports FDA Approval For Portico With FlexNav TAVR System - Quick Facts (RTTNews)
20.09.21	Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten